Details for New Drug Application (NDA): 062139
✉ Email this page to a colleague
NDA 062139 describes MINOCIN, which is a drug marketed by Bausch, Triax Pharms, Lederle, and Rempex, and is included in five NDAs. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the MINOCIN profile page.
The generic ingredient in MINOCIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
The generic ingredient in MINOCIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
Summary for 062139
| Tradename: | MINOCIN |
| Applicant: | Lederle |
| Ingredient: | minocycline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062139
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
